These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7007752)

  • 1. [Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
    Gerc V; Numić N
    Med Arh; 1980; 34(1):51-9. PubMed ID: 7007752
    [No Abstract]   [Full Text] [Related]  

  • 2. [An example of an acceptable combination in the treatment of arterial hypertension].
    Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
    Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
    Franz IW; Lohmann FW
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():325-7. PubMed ID: 347807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].
    Gasser RW; Brandstetter G; Skrabal F
    Wien Klin Wochenschr; 1982 Jan; 94(1):25-8. PubMed ID: 7080491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen.
    Salmela PI; Jounela AJ; Karppanen H
    Ann Clin Res; 1981 Dec; 13(6):433-8. PubMed ID: 6753709
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension with clofelin and adelfan-esidrex].
    Panikarskiĭ VG
    Vrach Delo; 1980 Sep; (9):60-2. PubMed ID: 7423954
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic equivalent of a single and divided daily dose of 2 Tri-Torrat coated tablets].
    Teufel W; Bartsch W; Glocke M; Häcker W
    MMW Munch Med Wochenschr; 1984 Feb; 126(7):181-4. PubMed ID: 6143259
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of the acetylator phenotype for the clinical use of dihydralazine.
    Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous administration of dihydralazine, propranolol and a diuretic in the treatment of severe hypertension].
    Chodakowska J; Cybulska I; Raczyński J
    Pol Arch Med Wewn; 1977 Dec; 58(6):541-6. PubMed ID: 600831
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 13. [A cross-over comparison of dihydralazine and minoxidil in severe hypertension (author's transl)].
    Rumboldt Z; Jurisić M; Bagatin J
    Lijec Vjesn; 1982 Feb; 104(2):64-8. PubMed ID: 7050574
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of dihydralazine infusion in the management of severe hypertension in pregnancy.
    Moodley J; Vasant RV
    Cent Afr J Med; 1986 Jun; 32(6):145-7. PubMed ID: 3568122
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of oxdralazine and dihydralazine in essential hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza W; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
    Tuckman J; Messerli F; Hodler J
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():159s-61. PubMed ID: 4593561
    [No Abstract]   [Full Text] [Related]  

  • 18. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
    Forrest WA
    Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetics of dihydralazine].
    Siegmund WS; Huller H; Franke H; Kallwellis R; Lupke A
    Farmakol Toksikol; 1982; 45(3):105-7. PubMed ID: 7095119
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydralazine therapy and acetylator phenotype.
    Iisalo E; Laine T; Lehtonen A; Sellman R
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.